Back to results
US 2026/0284652 A1Published application
Viral infections - treatment with convalescent plasma/serum
AssigneeRegen Lab USA LLC
InventorsAntoine Turzi, Andreas Pigni, Farid Gomri, Hosni Trabelsi
Life of this patent
Estimating the term…
Abstract
A container, method, and kit includes a thixotropic gel as a first layer from a distal end of the container; and a coagulation activator as a second layer disposed at a proximal end of the container above the thixotropic gel layer. The coagulation activator includes calcium gluconate at a concentration of about 1% to about 20%. The container contains no anticoagulant.
Claims21
A container comprising:
- a thixotropic gel as a first layer from a distal end of the container;
- and
- a coagulation activator as a second layer disposed at a proximal end of the container above the thixotropic gel layer, wherein the coagulation activator comprises calcium gluconate at a concentration of about 1% to about 20%,
- wherein the container contains no anticoagulant.
1 more element
A method comprising the steps of:
- (a) introducing whole blood or bone marrow from a donor into a container prefilled only with:
- (i) a thixotropic gel as a first layer from a distal end of the container, and
- (ii) calcium gluconate as a coagulation activator as a second layer disposed proximally above the thixotropic gel layer;
- (b) centrifuging the container once only at a force of about 1000 g to about 2000 g for about 15 to about 30 minutes;
- and
- (c) collecting the serum from a proximal end of the container immediately following centrifugation and without homogenizing or resuspending the contents of the container,
- wherein the centrifugation time in step (b) is reduced relative to the centrifugation time required for an equivalent container lacking a calcium-based coagulation activator.
4 more elements
A kit for use in the treatment and/or prophylaxis of a viral infection and/or associated condition, the kit comprising:
- at least one first container prefilled only with a thixotropic gel as a first layer from a distal end of the first container and calcium gluconate as a coagulation activator as a second layer disposed proximally above the thixotropic gel layer, the first container being configured for preparation of a serum;
- and
- at least one second container prefilled with a thixotropic gel and an anticoagulant comprising sodium citrate, the second container being configured for preparation of a plasma,
- wherein the serum prepared from the first container and the plasma prepared from the second container are for administration in combination to a subject in need thereof.
1 more element
A container prefilled only with:
- a cell selector gel as a first layer from a distal end of the container;
- and
- calcium gluconate as a second layer disposed at a proximal end of the container above the cell selector gel, wherein the calcium gluconate is at a concentration of about 1% to about 20%,
- wherein the container contains no anticoagulant.
1 more element
Dependencies are inferred from the claim text.